Your browser doesn't support javascript.
loading
Impact of biologic therapy on cancer outcomes in patients with immune checkpoint inhibitor-induced bullous pemphigoid.
Said, Jordan T; Talia, Jordan; Wei, Erin; Mostaghimi, Arash; Semenov, Yevgeniy; Giobbie-Hurder, Anita; Chen, Steven T; LeBoeuf, Nicole R.
Afiliación
  • Said JT; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts.
  • Talia J; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Wei E; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts.
  • Mostaghimi A; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts.
  • Semenov Y; Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.
  • Giobbie-Hurder A; Department of Biostatistics, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Chen ST; Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts. Electronic address: stchen@partners.org.
  • LeBoeuf NR; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts; Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Electronic address: nleboeuf@bwh.harvard.edu.
J Am Acad Dermatol ; 88(3): 670-671, 2023 03.
Article en En | MEDLINE | ID: mdl-35779636

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Penfigoide Ampolloso / Neoplasias Idioma: En Revista: J Am Acad Dermatol Año: 2023 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Penfigoide Ampolloso / Neoplasias Idioma: En Revista: J Am Acad Dermatol Año: 2023 Tipo del documento: Article